Emerging Technologies

Nissan Elimelech, founder of Augmedics, discusses the process of developing augmented reality surgical navigation technology and his next endeavor to develop the first AR glasses specifically for healthcare.

What they offer is not a passive but an active clinical assistant that thinks beyond consultation notes. 

Trained on two million skin images, it can perform a range of clinical tasks unlike current models.

Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.

Paul Grand, CEO of MedTech Innovator, offers advice for startups on pitching to accelerators, the value of scaling alongside an accelerator and how the company helps companies grow within healthcare in collaboration with major partners.

The partnership combines Atropos Health's expertise in real-world evidence generation with Databricks' data intelligence capabilities.  

Molly Gibson, president of future science at Lila Sciences, explains how the company's superintelligence will reshape research across life, chemical and material sciences.

Molly Gibson, president of future science at Lila Sciences, describes the company's scientific superintelligence computer that analyzes various branches of science and creates hypotheses to help researchers find treatments or cure diseases.

Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.